Advani, A. S., Sanford, B., Luger, S., Devidas, M., Larsen, E. C., Liedtke, M., … Stock, W. (2013). Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance). In BLOOD (Vol. 122, pp. 3903–3906). AMER SOC HEMATOLOGY.

Advani, Anjali S., Ben Sanford, Selina Luger, Meenakshi Devidas, Eric C. Larsen, Michaela Liedtke, Peter M. Voorhees, et al. “Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance).” In BLOOD, 122:3903–6. AMER SOC HEMATOLOGY, 2013.

Advani AS, Sanford B, Luger S, Devidas M, Larsen EC, Liedtke M, et al. Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance). In: BLOOD. AMER SOC HEMATOLOGY; 2013. p. 3903–6.

Advani, Anjali S., et al. “Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance).” BLOOD, vol. 122, no. 21, AMER SOC HEMATOLOGY, 2013, pp. 3903–06.

Advani AS, Sanford B, Luger S, Devidas M, Larsen EC, Liedtke M, Voorhees PM, Foster MC, Claxton DF, Geyer S, Parker E, Coffan K, Carroll WL, Winick NJ, Coutre SE, Tallman MS, Appelbaum FR, Erba HP, Stone RM, Hunger SP, Larson RA, Stock W. Frontline-Treatment Of Acute Lymphoblastic Leukemia (ALL) In Older Adolescents and Young Adults (AYA) Using a Pediatric Regimen Is Feasible: Toxicity Results of the Prospective US Intergroup Trial C10403 (Alliance). BLOOD. AMER SOC HEMATOLOGY; 2013. p. 3903–3906.